Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • Investor Portal
    • JOIN OUR TEAM
    • Contact

NEWS

Our Latest News

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

Global private equity healthcare specialist ARCHIMED further expands its presence in the Consumer Health sector with the acquisition of Groupe Laboratoire Rivadis.

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

ARCHIMED gives several million euros to the EURÊKA Foundation its philanthropic arm

 November

 25, 

2020

Partnering with existing owners and management, ARCHIMED acquires majority interest in NAMSA, the world leader in medical device testing

 September

 1, 

2020

ARCHIMED raises €1 billion for its MED Platform I Fund

 August

 28, 

2020

ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials

 May

 18, 

2020

Growth investment is set to accelerate Polyplus’ expansion in partnership with Warburg Pincus and ARCHIMED

 April

 29, 

2020

ARCHIMED’s Direct Healthcare Group acquires Patient Handling Europe

 April

 9, 

2020

< 1 … 9 10 11 12 13 … 17 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • Contact Us
  • Videos
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top